1. Home
  2. CAG vs PTGX Comparison

CAG vs PTGX Comparison

Compare CAG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

N/A

Current Price

$16.41

Market Cap

7.9B

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$153.44

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAG
PTGX
Founded
1919
2006
Country
United States
United States
Employees
17400
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
9.5B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
CAG
PTGX
Price
$16.41
$153.44
Analyst Decision
Hold
Strong Buy
Analyst Count
17
13
Target Price
$16.88
$108.23
AVG Volume (30 Days)
10.3M
448.6K
Earning Date
04-01-2026
05-07-2026
Dividend Yield
9.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.35
Revenue
$1,500,000,000.00
N/A
Revenue This Year
N/A
$874.25
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$64.12
Revenue Growth
N/A
N/A
52 Week Low
$12.53
$56.56
52 Week High
$20.32
$160.81

Technical Indicators

Market Signals
Indicator
CAG
PTGX
Relative Strength Index (RSI) 69.73 62.21
Support Level $15.96 $94.48
Resistance Level $17.83 N/A
Average True Range (ATR) 0.40 4.92
MACD 0.10 0.05
Stochastic Oscillator 94.41 74.71

Price Performance

Historical Comparison
CAG
PTGX

About CAG ConAgra Brands Inc.

Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: